395 related articles for article (PubMed ID: 26408164)
1. Endocannabinoids and Mental Disorders.
Rubino T; Zamberletti E; Parolaro D
Handb Exp Pharmacol; 2015; 231():261-83. PubMed ID: 26408164
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid system in psychotic and mood disorders, a review of human studies.
Garani R; Watts JJ; Mizrahi R
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110096. PubMed ID: 32898588
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
Kerr DM; Downey L; Conboy M; Finn DP; Roche M
Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Fernández-Ruiz J; Romero J; Ramos JA
Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and Endocannabinoid Signaling in Epilepsy.
Katona I
Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
[TBL] [Abstract][Full Text] [Related]
9. Distribution of the Endocannabinoid System in the Central Nervous System.
Hu SS; Mackie K
Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
Hryhorowicz S; Kaczmarek-Ryś M; Zielińska A; Scott RJ; Słomski R; Pławski A
Front Immunol; 2021; 12():790803. PubMed ID: 35003109
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
Tam J
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
[TBL] [Abstract][Full Text] [Related]
12. The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?
Steffens S; Pacher P
Curr Drug Targets; 2015; 16(4):334-41. PubMed ID: 25469884
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids and the Cardiovascular System in Health and Disease.
O'Sullivan SE
Handb Exp Pharmacol; 2015; 231():393-422. PubMed ID: 26408169
[TBL] [Abstract][Full Text] [Related]
14. Gut feelings about the endocannabinoid system.
Di Marzo V; Piscitelli F
Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid signaling and liver therapeutics.
Mallat A; Teixeira-Clerc F; Lotersztajn S
J Hepatol; 2013 Oct; 59(4):891-6. PubMed ID: 23567085
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
17. The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
Oppong-Damoah A; Gannon BM; Murnane KS
CNS Neurol Disord Drug Targets; 2022; 21(1):3-13. PubMed ID: 33573565
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system and the treatment of mood and anxiety disorders.
Hill MN; Gorzalka BB
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):451-8. PubMed ID: 19839936
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review.
Kruk-Slomka M; Dzik A; Budzynska B; Biala G
Mol Neurobiol; 2017 Dec; 54(10):8332-8347. PubMed ID: 27924524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
